Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0002047607-26-000006

Chief Strategy Officer gave up 588 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Riley Jennifer · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-10 Shares withheld for taxes : show line 1 in the form −588 $13.10 $7,703 39,696 D
Loading xslF345X06/form4-06122026_080614.xml…